about
Paraneoplastic thrombocytosis: the secrets of tumor self-promotionCheckpoint Inhibition in Hodgkin Lymphoma: Saving the Best for Last?Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF.Dyspnea in palliative care: expanding the role of corticosteroids.Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Myeloid Leukemia following Orthotopic Cardiac TransplantationAnemia in general medical inpatients prolongs length of stay and increases 30-day unplanned readmission rate.Paraneoplastic autoimmunity associated with testicular myeloid sarcoma and chronic myelomonocytic leukemiaPEComa with Transcription Factor E3 Overexpression: A Diagnostic and Therapeutic ChallengeLenalidomide for the treatment of cryoglobulinemia and undifferentiated spondyloarthropathy in a patient with multiple myeloma.Development of highly aggressive mantle cell lymphoma after sofosbuvir treatment of hepatitis C.Silence.Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis.Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma.Potentially inappropriate medication use in elderly non-Hodgkin lymphoma patients is associated with reduced survival and increased toxicities.Away from home.Pretransplant comprehensive geriatric assessment in hematopoietic cell transplantation: a single center experience.Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP 53 alterationsBurden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adultsMy very first narcotics prescriptionCommentary on "relation between prefracture characteristics and perioperative complications in the elderly adult patient with hip fracture"An unusual cause of chest pain: Mycobacterium avium complex and the immune reconstitution inflammatory syndromeBack to basicsCharacteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant RecipientsThe geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patientsFavorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34+ selected graftEnd-of-life care for older AML patients relapsing after allogeneic stem cell transplant at a dedicated cancer centerEvidence-Based Minireview: Longitudinal geriatric assessment in quality care for older patients with hematologic malignanciesFeasibility of a patient-reported, electronic geriatric assessment tool in hematopoietic cell transplantation - a single institution pilot studyImpact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignanciesImpact of allogeneic hematopoietic cell transplantation on immune evasive mechanisms in relapsed refractory large B-cell lymphoma
P50
Q26825427-0BBD105F-93EB-4CBF-A3CD-A6EF3A6FC8EFQ28078774-FA470368-3EEF-4EE0-A8FD-2E6E026B0A55Q35470449-AC02D68A-EF0E-4033-8720-F60E597D6197Q37989999-0A3CD215-7CF7-42BF-9A40-97614D975BC3Q38100792-11968DB8-D3BA-4446-BAD5-141865453C2AQ38104236-B7BD200E-8C30-42F9-A4F2-EE93F0A67356Q38160489-ACD9A70D-906C-4E88-86A4-D88C6A6F8CF7Q40954944-91616BCD-D236-4A05-895F-2EEE8699EE6FQ42557774-1F82C508-F834-407C-8077-FDCCD2B820C9Q42921960-5C65BE08-4F13-4323-A541-CFF940BC2D50Q46557295-80079B98-3A4D-4494-A025-CCA29AFF8332Q47959893-783AC080-52B7-4C58-B158-ADFEF7E19165Q48229580-EEC0F1BC-CAC5-4A13-A5C4-6245FB50A932Q48295024-40CDC37C-8A19-4147-9C64-55F576BB9219Q48407622-FA5CCB28-CB6E-4127-9427-D4DD9F86A321Q52663530-BD82ED6B-DA69-43F3-838A-75B3BCD97CD7Q60685711-C0F6DAC6-55D0-4C52-8896-6C577F19DE18Q60921241-2DA1138C-F915-466B-8F65-3651297454BAQ82054733-E52DA3E7-5D66-4CDF-83E2-7D690865C3BBQ84291400-87C92BD6-8385-4CF4-8051-C6BE9FCFEC3CQ84588046-9A80D8DA-CCB0-47AD-BDAB-B02672892131Q85846745-D487185F-0463-46E4-A41E-45EC0F947F58Q90682687-2FAAFEE8-E1E2-4426-9602-6D7A9AF15D7DQ90758321-DDAB61A2-4F43-4B26-BBD8-46F05FF51C1FQ90911364-42A6A8EB-B88E-47A1-A5D2-86615EE81D5AQ91089897-4841C281-4E22-4B56-9DCF-3C67F622A81EQ91752213-E696B053-1919-4355-A6CD-7CA529653FA4Q92942038-1BBF5608-B9E2-40B0-9343-F9EE200F5811Q93023578-FCBA9B83-6BC2-46C8-AC1E-85F9E09920F2Q94671651-AE63F3C4-1C11-4393-9E2E-A92DE19799F1
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Richard J Lin
@ast
Richard J Lin
@en
Richard J Lin
@es
Richard J Lin
@nl
Richard J Lin
@sl
type
label
Richard J Lin
@ast
Richard J Lin
@en
Richard J Lin
@es
Richard J Lin
@nl
Richard J Lin
@sl
prefLabel
Richard J Lin
@ast
Richard J Lin
@en
Richard J Lin
@es
Richard J Lin
@nl
Richard J Lin
@sl
P108
P106
P108
P21
P31
P496
0000-0002-0834-7880